1-20 of 28
Heiko Becker, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Relevance of Somatic Mutations in Chronic Myelomonocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation

Nico Gagelmann, Anita Badbaran, Rashit Bogdanov, PhD, Olivier Nibourel, Friedrich Stoelzel, MD, Christina Rautenberg, MD, Heiko Becker, MD, Aleksandar Radujkovic, MD, Michael Koldehoff, Prof, MD PhD, Maximilian Christopeit, PhD, Peter Dreger, Jürgen Finke, MD, Guido Kobbe, MD, Uwe Platzbecker, Marie Robin, MD, Dietrich W. Beelen, Nicolaus Kroeger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1713.
https://doi.org/10.1182/blood-2019-121969
Published: 2019
Journal Articles

Phase I/II Study on Cytarabine and Idarubicin Combined with Escalating Doses of Clofarabine in Untreated Patients with Acute Myeloid Leukemia and High Risk for Induction Failure (AMLSG 17-10 CIARA)

Juergen Krauter, MD, Walter Fiedler, MD, Richard F. Schlenk, MD, Peter Paschka, MD, Felicitas Thol, MD, Michael Lübbert, MD, Mohammad Amen Wattad, MD, Mareike Verbeek, Christian Koenecke, MD, Barbara Neuhaus, Maxim Kebenko, Melanie Janning, Konstanze Dohner, MD, Verena I. Gaidzik, MD, Heiko Becker, MD, Christine Greil, MD, Peter Reimer, MD, Katharina Götze, MD, Hartmut Döhner, MD, Arnold Ganser, MD, Michael Heuser, MD
Journal: Blood
Blood (2016) 128 (22): 4038.
https://doi.org/10.1182/blood.V128.22.4038.4038
Published: 2016
Journal Articles

Identification of a Novel Chromosomal Translocation t(11;16)(q23;q22) Fusing MLL to Enhancer of mRNA Decapping (EDC)-4 in Smoldering Acute Myeloid Leukemia

Heiko Becker, MD, Keisuke Kataoka, MD PhD, Gabriele Greve, Jesús Duque Afonso, MD, Tobias Ma, Sabine Bleul, Milena Pantic, PhD, Julia Schüler, DVM, PhD, Justus Duyster, MD, Michael L Cleary, MD, Seishi Ogawa, MD PhD, Michael Lübbert, MD
Journal: Blood
Blood (2016) 128 (22): 1696.
https://doi.org/10.1182/blood.V128.22.1696.1696
Published: 2016
Journal Articles

Elevated Pre-Treatment Fetal Hemoglobin Predicts Better Outcome in MDS/AML Patients Receiving 5-Aza-2'-Deoxycytidine (DAC)

Rainer Claus, MD, Gabriele Ihorst, PhD, Philipp Sander, Ljudmila Bogatyreva, Heiko Becker, MD, Pierre W Wijermans, MD, Stefan Suciu, Emmanuel Bissé, MD PhD, Michael Lübbert, MD
Journal: Blood
Blood (2016) 128 (22): 3175.
https://doi.org/10.1182/blood.V128.22.3175.3175
Published: 2016
Journal Articles

Single Cell Genotyping of Inv(16) AML in CBL Mutated Clonal Hematopoiesis Characterizes Clonal Architecture and Evolution of Exome Sequencing-Identified Mutations in the Protein Tyrosine Phosphatase Ptprt and Other Genes

Christoph Niemöller, Sabine Bleul, Nadja Blagitko-Dorfs, PhD, Christine Greil, MD, Kenichi Yoshida, MD PhD, Rainer Claus, MD, Dietmar Pfeifer, PhD, Seishi Ogawa, MD PhD, Michael Lübbert, MD, Heiko Becker, MD
Journal: Blood
Blood (2015) 126 (23): 3834.
https://doi.org/10.1182/blood.V126.23.3834.3834
Published: 2015
Journal Articles

Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia

Carla Donadoni, PhD, Rocco Piazza, MD PhD, Diletta Fontana, M.Sc., Andrea Parmiani, M.Sc., Alessandra Pirola, M.Sc., Sara Redaelli, PhD, Giovanni Signore, M.Sc., Vincenzo Piazza, PhD, Luca Malcovati, MD, Roberta Spinelli, M.Sc., Vera Magistroni, PhD, Giuseppe Gaipa, Marco Peronaci, M.Sc., Alessandro Morotti, MDPhD, Cristina Panuzzo, PhD, Giuseppe Saglio, MD, Elena Maria Elli, MD, Emilio Usala, MD, Dong-Wook Kim, MD PhD, Delphine Rea, MDPhD, Konstantinos Zervakis, MD, Nora-Athina Viniou, MD, Argiris Symeonidis, MD, Heiko Becker, MD, Jacqueline Boultwood, PhD, Leonardo Campiotti, MD, Matteo G Carrabba, MD, Graham R Bignell, PhD, Elli Papaemmanuil, PhD, Peter J Campbell, PhD, Mario Cazzola, MD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2014) 124 (21): 2212.
https://doi.org/10.1182/blood.V124.21.2212.2212
Published: 2014
Journal Articles

Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group

Heiko Becker, MD, Stefan Suciu, PhD, Björn Rüter, MD, Uwe Platzbecker, MD, PhD, Aristoteles Giagounidis, MD, Dominik Selleslag, MD, Boris Labar, MD, PhD, Ulrich Germing, MD, Helmut R. Salih, MD, Petra Muus, MD, PhD, Karl-Heinz Pflüger, MD, Anne Hagemeijer, MD, PhD, Hans-Eckart Schaefer, MD, Frédéric Baron, MD, PhD, Arnold Ganser, MD, Carlo Aul, MD, Theo de Witte, MD, Pierre W. Wijermans, MD, Michael Lübbert, MD
Journal: Blood
Blood (2013) 122 (21): 1452.
https://doi.org/10.1182/blood.V122.21.1452.1452
Published: 2013
Journal Articles

Identification Of a Novel Mode Of Kinase Inhibitor Resistance In JAK2: JAK2 Inhibitor Resistance Is Mediated By The Generation Of 45-Kda JAK2 Variant Which Alters The Kinase Domain Structure

Sivahari Prasad Gorantla, Ph.D, Nikolas von Bubnoff, M.D, Martina Rudelius, M.D, Corinna Albers, Ph.D, Anna Lena Illert, M.D, Heiko Becker, MD, Christian Peschel, Justus Duyster
Journal: Blood
Blood (2013) 122 (21): 113.
https://doi.org/10.1182/blood.V122.21.113.113
Published: 2013
Journal Articles

Differential Clinical Impact Of Gene Mutations and Their Combinations In Primary Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Dimitrios Papaioannou, MD, Kati Maharry, MAS, Krzysztof Mrózek, MD, PhD, Heiko Becker, MD, Klaus H. Metzeler, MD, Jason H. Mendler, MD, PhD, Susan P. Whitman, PhD, Ann-Kathrin Eisfeld, MD, Sebastian Schwind, MD, Yue-Zhong Wu, MS, Deedra Nicolet, MS, Jonathan E. Kolitz, MD, Maria R. Baer, MD, Bayard L. Powell, MD, Donna Bucci, Michael A. Caligiuri, MD, Andrew J. Carroll, PhD, Stefano Volinia, PhD, Richard M. Stone, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2013) 122 (21): 2540.
https://doi.org/10.1182/blood.V122.21.2540.2540
Published: 2013
Journal Articles

Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)

Susan Whitman, PhD, Jessica Kohlschmidt, PhD, Kati Maharry, MAS, Deedra Nicolet, MS, Sebastian Schwind, MD, Heiko Becker, MD, Klaus H. Metzeler, MD, Krzysztof Mrózek, MD, PhD, Jason H. Mendler, MD, PhD, Ann-Kathrin Eisfeld, MD, Stefano Volinia, PhD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Jonathan E. Kolitz, MD, Richard M. Stone, MD, Il-Kyoo Park, Michael A. Caligiuri, M.D., Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2012) 120 (21): 1293.
https://doi.org/10.1182/blood.V120.21.1293.1293
Published: 2012
Journal Articles

SPARC contributes to Leukemia Growth and Aggressive Disease in Acute Myeloid Leukemia (AML)

Houda Alachkar, PharmD, Kati Maharry, MAS, Ramasamy Santhanam, Ph.D, Paolo Neviani, Ph.D, Stefano Volinia, PhD, Jessica Kohlschmidt, PhD, Klaus H. Metzeler, MD, Adrienne M Dorrance, Ph.D, Sebastian Schwind, MD, Heiko Becker, MD, Jason H. Mendler, MD, PhD, Ann-Kathrin Eisfeld, MD, Susan Whitman, PhD, Krzysztof Mrózek, MD, PhD, Ramiro Garzon, MD, Danilo Perrotti, MD, Ph.D, Michael A. Caligiuri, M.D., Richard M. Stone, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2012) 120 (21): 773.
https://doi.org/10.1182/blood.V120.21.773.773
Published: 2012
Journal Articles

The Clinical Role of Micrornas (miRs) in Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML): miR-155 Upregulation Independently Identifies High-Risk Patients (Pts)

Guido Marcucci, MD, Kati Maharry, MAS, Klaus H. Metzeler, MD, Stefano Volinia, PhD, Yue-Zhong Wu, MS, Krzysztof Mrózek, MD, PhD, Deedra Nicolet, MS, Jessica Kohlschimdt, Susan Whitman, PhD, Jason H. Mendler, MD, PhD, Sebastian Schwind, MD, Heiko Becker, MD, Ann-Kathrin Eisfeld, MD, Andrew J. Carroll, PhD, Bayard L. Powell, MD, Jonathan E. Kolitz, MD, Ramiro Garzon, MD, Michael A. Caligiuri, M.D., Richard M. Stone, MD, Clara D Bloomfield
Journal: Blood
Blood (2012) 120 (21): 1387.
https://doi.org/10.1182/blood.V120.21.1387.1387
Published: 2012
Journal Articles

Impact of DNMT3A mutations on Clinical Response to the Hypomethylating Agent Decitabine in Older Patients (pts) with Acute Myeloid Leukemia (AML)

Alison R. Walker, MD, Klaus H. Metzeler, MD, Susan Geyer, PhD, Heiko Becker, MD, Sebastian Schwind, MD, Susan P. Whitman, PhD, John Curfman, Yue-Zhong Wu, MS, Danilo Perrotti, MD, Ph.D, Rebecca B. Klisovic, MD, Ramiro Garzon, MD, William Blum, MD, Guido Marcucci, MD
Journal: Blood
Blood (2011) 118 (21): 944.
https://doi.org/10.1182/blood.V118.21.944.944
Published: 2011
Journal Articles

Poor Outcome of RUNX1 -Mutated ( RUNX1 -mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures,

Jason H. Mendler, MD, PhD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Krzysztof Mrózek, MD, PhD, Jessica Kohlschmidt, PhD, Deedra Nicolet, MS, Heiko Becker, MD, Klaus H. Metzeler, MD, Sebastian Schwind, MD, Susan P. Whitman, PhD, William Blum, MD, Bayard L. Powell, MD, Jonathan E. Kolitz, MD, Thomas H. Carter, MD, PhD, Meir Wetzler, MD, Joseph O. Moore, MD, Andrew J. Carroll, PhD, Maria R. Baer, MD, Richard A. Larson, MD, Michael A Caligiuri, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 3454.
https://doi.org/10.1182/blood.V118.21.3454.3454
Published: 2011
Journal Articles

ASXL1 Mutations Identify a High-Risk Subgroup of Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia within the European LeukemiaNet ‘Favorable' Genetic Category

Klaus H. Metzeler, MD, Heiko Becker, MD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MD, PhD, Deedra Nicolet, MS, Susan P. Whitman, PhD, Yue-Zhong Wu, MS, Sebastian Schwind, MD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Meir Wetzler, MD, Joseph O. Moore, MD, Jonathan E. Kolitz, MD, Maria R. Baer, MD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Michael A Caligiuri, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 417.
https://doi.org/10.1182/blood.V118.21.417.417
Published: 2011
Journal Articles

Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)

Krzysztof Mrózek, MD, PhD, Guido Marcucci, MD, Kati Maharry, MAS, Deedra Nicolet, MS, Heiko Becker, MD, Susan P. Whitman, PhD, Klaus H. Metzeler, MD, Sebastian Schwind, MD, Yue-Zhong Wu, MS, Jessica Kohlschmidt, PhD, Mark J. Pettenati, PhD, Prasad R. K. Koduru, PhD, Nyla A. Heerema, PhD, Annemarie W. Block, PhD, Shivanand R. Patil, PhD, Maria R. Baer, MD, Jonathan E. Kolitz, MD, Joseph O. Moore, MD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 414.
https://doi.org/10.1182/blood.V118.21.414.414
Published: 2011
Journal Articles

MiR-3151 , a Novel MicroRNA Embedded in BAALC , Is Only Weakly Co-Expressed with Its Host Gene and Independently Impacts on the Clinical Outcome of Older Patients (Pts) with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Ann-Kathrin Eisfeld, MD, Guido Marcucci, MD, Kati Maharry, MAS, Sebastian Schwind, MD, Michael D. Radmacher, PhD, Deedra Nicolet, MS, Heiko Becker, MD, Susan P. Whitman, PhD, Klaus H. Metzeler, MD, Krzysztof Mrózek, MD, PhD, Yue-Zhong Wu, MS, Maria R. Baer, MD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Joseph O. Moore, MD, Jonathan E. Kolitz, MD, Meir Wetzler, MD, Michael A Caligiuri, MD, Richard A. Larson, MD, Stephan M. Tanner, PhD, Albert de la Chapelle, MD, PhD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 1462.
https://doi.org/10.1182/blood.V118.21.1462.1462
Published: 2011
Journal Articles

Single Cell Network Profiling as a Platform to Reveal Leukemia-Specific Signaling Signatures and Sensitivity to Kinase Inhibitor Therapies

Todd M. Covey, Michael Gulrajani, Heiko Becker, MD, Jason C. Chandler, MD, Sebastian Schwind, MD, Guido Marcucci, MD, Alessandra Cesano, MD
Journal: Blood
Blood (2010) 116 (21): 2753.
https://doi.org/10.1182/blood.V116.21.2753.2753
Published: 2010
Journal Articles

Sole Trisomy 8 In Patients (pts) with De Novo Acute Myeloid Leukemia (AML) Is Associated with Age-Independent Poor Outcome That Is Modified by Molecular Markers and with Unique Gene- and Microrna (miR)-Signatures: a Cancer and Leukemia Group B (CALGB) Study

Heiko Becker, MD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Dean Margeson, MAS, Krzysztof Mrózek, MD, PhD, Susan P. Whitman, PhD, Yue-Zhong Wu, MS, Klaus H. Metzeler, MD, Sebastian Schwind, MD, Kelsi B. Holland, MS, Jonathan E. Kolitz, MD, Andrew J. Carroll, PhD, Michael A. Caligiuri, MD, Maria R. Baer, MD, Richard A. Larson, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2010) 116 (21): 577.
https://doi.org/10.1182/blood.V116.21.577.577
Published: 2010
Journal Articles

Interleukin-15 Is a Proto-Oncogene In Acute Large Granular Lymphocyte Leukemia

Anjali Mishra, Ph.D., Shujun Liu, Ph.D., Gregory H Sams, Douglas P Curphey, Ramasamy Santhanam, PhD, Laura J Rush, DVM, PhD, Deanna Schaefer, DVM, Lauren G Falkenberg, Laura Sullivan, Laura Jaroncyk, Xunchang Zou, MS, Harold Fisk, PhD, Jadwiga Labanowska, MS, Enrico Caserta, PhD, Lai-Chu Wu, MD, PhD, Heiko Becker, MD, Sebastian Schwind, MD, Jason C. Chandler, MD, Yue-Zhong Wu, MS, Nyla A. Heerema, Ph.D., Pierluigi Porcu, MD, Ramiro Garzon, MD, Guido Marcucci, MD, Michael A. Caligiuri, MD
Journal: Blood
Blood (2010) 116 (21): 704.
https://doi.org/10.1182/blood.V116.21.704.704
Published: 2010